| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |